N-acetyl-L-cysteine enhances the osteogenic differentiation and inhibits the adipogenic differentiation through up regulation of Wnt 5a and down regulation of PPARG in bone marrow stromal cells

Biomedicine and Pharmacotherapy

Volumn 65, Issue 5, 2011, Pages 369-374

  Ji, HuiJiao ^a   Liu, YuKan ^a   Zhao, XiaoLi ^a   Zhang, Ming ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bone marrow stromal cells; Differentiation; N acetyl L cysteine

Indexed keywords

ACETYLCYSTEINE; ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; FAT DROPLET; FATTY ACID BINDING PROTEIN 4; LIPOPROTEIN LIPASE; MESSENGER RNA; MINERAL; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; WNT3A PROTEIN; WNT5A PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; STROMA CELL; UPREGULATION;

ACETYLCYSTEINE; ADIPOGENESIS; ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN; DOWN-REGULATION; FATTY ACID-BINDING PROTEINS; LIPID METABOLISM; LIPOPROTEIN LIPASE; OSTEOGENESIS; OSTEOPONTIN; PPAR GAMMA; RABBITS; STROMAL CELLS; UP-REGULATION; WNT PROTEINS;

EID: 79960958675     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.04.020     Document Type: Article

References (35)

1. Honig S. Osteoporosis - new treatments and updates. Bull NYU Hosp Jt Dis 2010, 68:166-170.
2. Bachmeyer C., Gauthier M. How to prevent glucocorticoid-induced osteoporosis. Cleve Clin J Med 2010, 77:762.
3. Simmons S. Osteoporosis. Nursing 2011, 41:35.
4. Roux S. New treatment targets in osteoporosis. Joint Bone Spine 2010, 77:222-228.
5. Ichioka N., Inaba M., Kushida T., et al. Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. Stem Cells 2002, 20:542-551.
6. Teitelbaum S.L. Stem cells and osteoporosis therapy. Cell Stem Cell 2010, 7:553-554.
7. Bielby R., Jones E., McGonagle D. The role of mesenchymal stem cells in maintenance and repair of bone. Injury 2007, 38:S26-S32.
8. Nuttall M.E., Gimble J.M. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 2004, 4:290-294.
9. Cotgreave I.A. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 1996, 38:205-227.
10. Polson J., Lee W.M. AASLD position paper: the management of acute liver failure. Hepatology 2005, 41:1179-1197.
11. Dilger R.N., Baker D.H. Oral N-acetyl-L-cysteine is a safe and effective precursor of cysteine. J Anim Sci 2007, 85:1712-1718.
12. Liu Y.K., Wang G.C., Cai Y.R., Ji H.J., et al. In vitro effects of nanophase hydroxyapatite particles on proliferation and osteogenic differentiation of bone marrow derived mesenchymal stem cells. J Biomed Mater Res A 2009, 90:1083-1091.
13. Dennis J.E., Merriam A., Awadallah A., et al. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 1999, 14:700-709.
14. Rozman C., Feliu E., Berga L., et al. Age related variations of fat tissue fraction in normal bone marrow depend both on size and number of adipocytes: a stereological study. Exp Hematol 1989, 17:34-37.
15. Song C., Guo Z., Ma Q., et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 2003, 308:458-462.
16. Dworetzky S.I., Fey E.G., Penman S., et al. Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc Natl Acad Sci 1990, 87:4605-4609.
17. Aronow M.A., Gerstenfeld L.C., Owen T., et al. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 1990, 143:213-221.
18. Marie P.J. Fromigué O. Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 2006, 1:539-548.
19. Ling L., Nurcombe V., Cool S.M. Wnt signaling controls the fate of mesenchymal stem cells. Gene 2009, 433:1-7.
20. Boland G.M., Perkins G., Hall D.J., Tuan R.S. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 2004, 93:1210-1230.
21. Zhou H., Yang X., Wang N., et al. Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells. Mol Cell Endocrinol 2007, 270:17-22.
22. Allen R.E., Boxhorn L.K. Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor. J Cell Physiol 1989, 138:311-315.
23. Ewton D.Z., Florini J.R. Relative effects of the somatomedins. Multiplication-stimulating activity, and growth hormone on myoblasts and myotubes in culture. Endocrinology 1980, 106:577-583.
24. Ewton D.Z., Florini J.R. Effects of the somatomedins and insulin on myoblast differentiation in vitro. Dev Biol 1981, 86:31-39.
25. Rosen E.D., Walkey C.J., Puigserver P., Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev 2000, 14:1293-1307.
26. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006, 7:885-896.
27. Muruganandan S., Roman C., Sinal C.J. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 2009, 66:236-253.
28. Akune T., Ohba S., Kamekura S., et al. PPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004, 113:846-855.
29. Takada I., Mihara M., Suzawa M., et al. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-γ transactivation. Nat Cell Biol 2007, 9:1273-1285.
30. Li X., Cui Q., Kao C., et al. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 2003, 33:652-659.
31. Lingjie Fu L.J., Tang T.T., Miao Y.Y. Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation. Bone 2008, 43:40-47.
32. Baek K.H., Lee W.Y., Oh K.W., et al. The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells. J Korean Med Sci 2005, 20:438-444.
33. Wang B.L., Sun W., Shi Z.C., et al. Decreased proliferation of mesenchymal stem cells in corticosteroid-induced osteonecrosis of femoral head. Orthopedics 2008, 31:444.
34. Ke B., Xu Z.L., Ling Y.F. Modulation of experimental osteoporosis in rats by the antioxidant beverage effective microorganism-X (EM-X). Biomed Pharmacother 2009, 63:114-119.
35. De Vries N., De Flora S. N-acetyl-l-cysteine. J Cell Biochem 1993, 53:270-277.